GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (NAS:IDXX) » Definitions » Cyclically Adjusted PS Ratio

IDEXX Laboratories (IDEXX Laboratories) Cyclically Adjusted PS Ratio : 15.55 (As of Apr. 27, 2024)


View and export this data going back to 1991. Start your Free Trial

What is IDEXX Laboratories Cyclically Adjusted PS Ratio?

As of today (2024-04-27), IDEXX Laboratories's current share price is $499.30. IDEXX Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $32.10. IDEXX Laboratories's Cyclically Adjusted PS Ratio for today is 15.55.

The historical rank and industry rank for IDEXX Laboratories's Cyclically Adjusted PS Ratio or its related term are showing as below:

IDXX' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 5.06   Med: 13.19   Max: 30.79
Current: 15.24

During the past years, IDEXX Laboratories's highest Cyclically Adjusted PS Ratio was 30.79. The lowest was 5.06. And the median was 13.19.

IDXX's Cyclically Adjusted PS Ratio is ranked worse than
94.81% of 135 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.21 vs IDXX: 15.24

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

IDEXX Laboratories's adjusted revenue per share data for the three months ended in Dec. 2023 was $10.741. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $32.10 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


IDEXX Laboratories Cyclically Adjusted PS Ratio Historical Data

The historical data trend for IDEXX Laboratories's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Cyclically Adjusted PS Ratio Chart

IDEXX Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.41 24.50 27.04 14.34 17.29

IDEXX Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.34 16.89 16.39 13.85 17.29

Competitive Comparison of IDEXX Laboratories's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, IDEXX Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEXX Laboratories's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's Cyclically Adjusted PS Ratio falls into.



IDEXX Laboratories Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

IDEXX Laboratories's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=499.30/32.1
=15.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDEXX Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, IDEXX Laboratories's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=10.741/129.4194*129.4194
=10.741

Current CPI (Dec. 2023) = 129.4194.

IDEXX Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 3.441 99.695 4.467
201406 3.766 100.560 4.847
201409 3.805 100.428 4.903
201412 3.633 99.070 4.746
201503 4.004 99.621 5.202
201506 4.383 100.684 5.634
201509 4.375 100.392 5.640
201512 4.353 99.792 5.645
201603 4.597 100.470 5.922
201606 5.137 101.688 6.538
201609 4.919 101.861 6.250
201612 4.887 101.863 6.209
201703 5.134 102.862 6.460
201706 5.663 103.349 7.092
201709 5.512 104.136 6.850
201712 5.683 104.011 7.071
201803 6.045 105.290 7.430
201806 6.555 106.317 7.979
201809 6.167 106.507 7.494
201812 6.256 105.998 7.638
201903 6.580 107.251 7.940
201906 7.078 108.070 8.476
201909 6.905 108.329 8.249
201912 6.938 108.420 8.282
202003 7.224 108.902 8.585
202006 7.379 108.767 8.780
202009 8.326 109.815 9.812
202012 8.288 109.897 9.760
202103 8.948 111.754 10.362
202106 9.534 114.631 10.764
202109 9.368 115.734 10.476
202112 9.299 117.630 10.231
202203 9.777 121.301 10.431
202206 10.141 125.017 10.498
202209 10.006 125.227 10.341
202212 9.884 125.222 10.215
202303 10.722 127.348 10.896
202306 11.236 128.729 11.296
202309 10.900 129.860 10.863
202312 10.741 129.419 10.741

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


IDEXX Laboratories  (NAS:IDXX) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


IDEXX Laboratories Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


IDEXX Laboratories (IDEXX Laboratories) Business Description

Address
One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.
Executives
James F Polewaczyk officer: Corporate Vice President IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
Jonathan Jay Mazelsky director, officer: President and CEO ONE IDEXX DRIVE, WESTBROOK ME 04092
Martin Alexander Smith officer: Executive Vice President C/O IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
Jonathan W Ayers director, officer: President & CEO IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
Michael Lane officer: Executive Vice President C/O IDEXX LABORATORIES, INC., WESTBROOK ME 04092
Irene Chang Britt director CAMPBELL SOUP COMPANY, ONE CAMPBELL PLACE, CAMDEN NJ 08103
Bruce L. Claflin director 7035 RIDGE ROAD, HANOVER MD 21076
Samer Abdul Samad director 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Stuart Essig director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Lawrence D Kingsley director C/O IDEX CORPORATION, 630 DUNDEE ROAD, NORTHBROOK IL 60062
Asha Collins director IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
M Anne Szostak director C/O TUPPERWARE BRANDS CORP, 14901 S ORANGE BLOSSOM TR, ORLANDO FL 32837
Sharon E. Underberg officer: EVP, GC & Corporate Secretary EASTMAN KODAK COMPANY, 343 STATE STREET, ROCHESTER NY 14650
Sophie V. Vandebroek director 6 OAK MEADOW ROAD, LINCOLN MA 01770
Daniel M Junius director C/O IMMUNOGEN, INC., 830 WINTER STREET, WALTHAM MA 02451